BusinessAbeona Reports Third Quarter 2017 Financial Results and Recent Business HighlightsBy Nasdaq OMXNov 15, 2017, 1:25 PM UTC
BusinessAbeona Enrolls First Subject in Spain in Ongoing Phase 1/2 Clinical Trial in MPS IIIABy Nasdaq OMXNov 9, 2017, 1:45 PM UTC
BusinessAbeona Therapeutics Enrolls First Two Patients in Pivotal Expansion of Phase 1/2 Clinical Trial in MPS IIIABy Nasdaq OMXOct 11, 2017, 12:19 PM UTC
BusinessAbeona Therapeutics and Brammer Bio Announce Collaboration for Commercial Translation of ABO-102By Nasdaq OMXSep 28, 2017, 12:32 PM UTC
BusinessVoyager Therapeutics Announces Publication from the California Institute of Technology of a Second-Generation Gene Therapy Capsid Demonstrating Further Enhanced Gene Transfer to the BrainBy Nasdaq OMXJul 17, 2017, 11:04 AM UTC
